GLP-1 therapies, or glucagon-like peptide-1 compounds, represent a substantial shift in how we treat type 2 diabetes . These prescription therapies help stimulating the body’s inherent GLP-1 process, https://bookmarkpagerank.com/story21788665/glp-1-a-major-approach-in-glucose-treatment